Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Short report: variation in mitochondrial 12S and 16S ribosomal DNA sequences in natural populations of Triatoma infestans (Hemiptera: Reduviidae).
- B. A. García, Candela Manfredi, L. Fichera, E. Segura
- Biology, Medicine
- The American journal of tropical medicine and…
- 1 June 2003
Mitochondrial DNA sequences of the 12S and 16S ribosomal RNA genes were analyzed in five natural populations of the Chagas' disease vector Triatoma infestans from Argentina. DNA sequence comparisons… Expand
Promising Efficacy of Benznidazole Nanoparticles in Acute Trypanosoma cruzi Murine Model: In-Vitro and In-Vivo Studies.
- M. L. Scalise, E. Arrúa, M. S. Rial, M. Esteva, C. Salomon, L. Fichera
- Biology, Medicine
- The American journal of tropical medicine and…
- 3 August 2016
The aim of this study was to evaluate the effectiveness of benznidazole nanoparticles (BNZ-nps) on trypomastigote forms and on intracellular infection in mammalian cells and primary cardiac myocyte… Expand
Intracellular Growth of Trypanosoma cruzi in Cardiac Myocytes Is Inhibited by Cytokine-Induced Nitric Oxide Release
- L. Fichera, M. Albareda, S. Laucella, M. Postan
- Medicine, Biology
- Infection and Immunity
- 1 January 2004
ABSTRACT The effect of interleukin-1β (IL-1β), tumor necrosis factor alpha (TNF-α), and gamma interferon (IFN-γ) on Trypanosoma cruzi multiplication and nitric oxide (NO) production in cardiac… Expand
In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi.
- J. Bua, A. M. Ruiz, M. Potenza, L. Fichera
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 20 September 2004
Cyclosporin A (CsA) nonimmunosuppressive analogs were evaluated against Trypanosoma cruzi and on TcCyP19, a cyclophilin of 19 kDa. Two out of eight CsA analogs, H-7-94 and F-7-62 showed the best… Expand
Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs.
- Noelia L Grosso, J. Bua, +4 authors L. Fichera
- Biology, Medicine
- Experimental parasitology
- 1 October 2010
We describe some biological and molecular characteristics of a Trypanosoma cruzi isolate derived from a Triatomine captured in Nicaragua. PCR based typification showed that this isolate, named… Expand
Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of Cyclosporin A binding proteins.
- M. Potenza, A. Galat, +6 authors J. Búa
- Biology, Medicine
- Parasitology
- 1 June 2006
The Trypanosoma cruzi cyclophilin gene family comprises 15 paralogues whose nominal masses vary from 19 to 110 kDa, namely TcCyP19, TcCyP20, TcCyP21, TcCyP22, TcCyP24, TcCyP25, TcCyP26, TcCyP28,… Expand
Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.
- J. Bua, L. Fichera, +6 authors A. M. Ruiz
- Biology, Medicine
- Parasitology
- 1 February 2008
Cyclophilins are target molecules for cyclosporin A (CsA), an immunosuppressive antimicrobial drug. We have previously reported the in vitro anti-Trypanosoma cruzi activity of H-7-94 and F-7-62… Expand
Polyfunctional T Cell Responses in Children in Early Stages of Chronic Trypanosoma cruzi Infection Contrast with Monofunctional Responses of Long-term Infected Adults
- M. Albareda, A. D. de Rissio, +9 authors S. Laucella
- Biology, Medicine
- PLoS neglected tropical diseases
- 1 December 2013
Background Adults with chronic Trypanosoma cruzi exhibit a poorly functional T cell compartment, characterized by monofunctional (IFN-γ-only secreting) parasite-specific T cells and increased levels… Expand
Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes
- M. Albareda, M. A. Natale, +14 authors S. Laucella
- Medicine
- Front. Immunol.
- 13 September 2018
Background: In contrast to adults, Trypanosoma cruzi-infected children have more broadly functional Trypanosoma cruzi-specific T cells, and the total T-cell compartment exhibits fewer signs of immune… Expand
Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease
- M. S. Rial, M. L. Scalise, E. Arrúa, M. Esteva, C. Salomon, L. Fichera
- Medicine
- PLoS neglected tropical diseases
- 1 December 2017
Background Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma cruzi (T. cruzi) that affects more than 6 million people, mainly in Latin America. Benznidazole is… Expand